AI assistant
Sending…
GENTEX CORP — Director's Dealing 2017
Feb 21, 2017
30893_dirs_2017-02-21_6b600344-518b-4aab-aea9-70f9cd325b70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2017-02-16
Reporting Person: Matthews Joseph E IV (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-16 | Common Stock | A | 2750.00 | $0.00 | Acquired | 18120.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-16 | Employee Stock Option (Right to buy) | $20.52 | A | 5680.00 | Acquired | 2024-02-16 | Common Stock (5680.00) | Direct |
Footnotes
F1: Shares vest 100% five years from grant award date.
F2: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan.
F3: Options granted under the Gentex Corporation Employee Stock Option Plan, which is a Rule 16B-3 Plan.
F4: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19